Fundies. English
Segment disclosures
Company overviewRegional Health Properties, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
35 dimension combinations 315 retained observations 30 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Pharmacy Revenues · Pharmacy Service
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=rhep:PharmacyRevenuesMember;us-gaap:StatementBusinessSegmentsAxis=rhep:PharmacyServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 9640000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 17227000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 7587000 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 11708000 | USD | 20260402 | Open filing evidence |
Health Care Patient Service · Healthcare Services Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePatientServiceMember;us-gaap:StatementBusinessSegmentsAxis=rhe:HealthcareServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 8774000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14416000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 11273000 | USD | 20250331 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2585000 | USD | 20241119 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2525000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4834000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2309000 | USD | 20250515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8835000 | USD | 20250331 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2136000 | USD | 20241119 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4442000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1916000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 22060000 | USD | 20240401 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000 | USD | 20220531 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9485000 | USD | 20220222 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2309000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7444000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2445000 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 5135000 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 2690000 | USD | 20220531 | Open filing evidence |
Health Care Patient Service · Healthcare Services Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePatientServiceMember;us-gaap:StatementBusinessSegmentsAxis=rhep:HealthcareServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 14001000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 26716000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 12715000 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 36050000 | USD | 20260402 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 8774000 | USD | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14416000 | USD | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 5642000 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 11273000 | USD | 20260402 | Open filing evidence |
Management Service · Real Estate Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ManagementServiceMember;us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 1050000 | USD | 20240401 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1045000 | USD | 20240401 | Open filing evidence |
Management Service · Real Estate Services Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ManagementServiceMember;us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 263000 | USD | 20241119 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 788000 | USD | 20241119 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 247000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 525000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 278000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 265000 | USD | 20220531 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1021000 | USD | 20220222 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 248000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 743000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 247000 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 495000 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 248000 | USD | 20220531 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1001000 | USD | 20220222 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 244000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 732000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 244000 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 488000 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 244000 | USD | 20210601 | Open filing evidence |
Management Service · Real Estate Services Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ManagementServiceMember;us-gaap:StatementBusinessSegmentsAxis=RHE:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 1021000 | USD | 20230214 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1001000 | USD | 20230214 | Open filing evidence |
Product And Service Other · Real Estate Services Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 107000 | USD | 20241119 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 103000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 107000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7000 | USD | 20220531 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 91000 | USD | 20220222 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 9000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 84000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 13000 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 75000 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 62000 | USD | 20220531 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 253000 | USD | 20220222 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 215000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 224000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2000 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 9000 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 7000 | USD | 20210601 | Open filing evidence |
Product And Service Other · Real Estate Services Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=RHE:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 91000 | USD | 20230214 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 253000 | USD | 20230214 | Open filing evidence |
Assisted Living Facilities
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=adk:AssistedLivingFacilitiesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2012-07-01 – 2012-09-30 | 3364000 | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-09-30 | 10038000 | USD | 20131022 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 3413000 | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-06-30 | 6676000 Restated | USD | 20131022 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 2463000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-09-30 | 7214000 | USD | 20131022 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 2410000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-06-30 | 4751000 | USD | 20131022 | Open filing evidence |
Skilled Nursing Facilities
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=adk:SkilledNursingFacilitiesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2012-07-01 – 2012-09-30 | 54408000 Restated | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-09-30 | 145305000 Restated | USD | 20131022 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 47853000 Restated | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-06-30 | 90897000 Restated | USD | 20131022 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 37729000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-09-30 | 97382000 | USD | 20131022 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 31462000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-06-30 | 59653000 | USD | 20131022 | Open filing evidence |
Health Care Service
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:HealthCareServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 7769000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14650000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 4570000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 6881000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2309000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7444000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2445000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 5135000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 2690000 | USD | 20230214 | Open filing evidence |
Health Care Service · Patient Care Revenues
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:HealthCareServiceMember;srt:ProductOrServiceAxis=RHE:PatientCareRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 7769000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14650000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 4570000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 6881000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2309000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7444000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2445000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 5135000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 2690000 | USD | 20230214 | Open filing evidence |
Healthcare Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:HealthcareServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 24247000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 8774000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14416000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 5642000 | USD | 20250515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 11273000 | USD | 20250331 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2585000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 7418000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2525000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4834000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2309000 | USD | 20250515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8835000 | USD | 20250331 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2136000 | USD | 20241119 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6577000 | USD | 20241119 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2526000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4442000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1916000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 22060000 | USD | 20240401 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 7769000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14650000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 4570000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 6881000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9485000 | USD | 20230414 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2309000 | USD | 20221122 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7444000 | USD | 20221122 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2445000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 5135000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 2690000 | USD | 20220531 | Open filing evidence |
Healthcare Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:HealthcareServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 9485000 | USD | 20230214 | Open filing evidence |
Healthcare Services Segment · Health Care Patient Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:HealthcareServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePatientServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 9831000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 24247000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 5642000 | USD | 20250515 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 7418000 | USD | 20241119 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4834000 | USD | 20240813 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2136000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6577000 | USD | 20241119 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2526000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4442000 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1916000 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 22060000 | USD | 20230414 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 7769000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14650000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 4570000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 6881000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9485000 | USD | 20230414 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2309000 | USD | 20221122 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 7444000 | USD | 20221122 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2445000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 5135000 | USD | 20220823 | Open filing evidence |
Healthcare Services Segment · Health Care Patient Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:HealthcareServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePatientServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 9485000 | USD | 20230214 | Open filing evidence |
Pharmacy Service
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:PharmacyServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 4004000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4004000 | USD | 20251114 | Open filing evidence |
Pharmacy Service · Pharmacy Revenues
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:PharmacyServiceMember;srt:ProductOrServiceAxis=rhe:PharmacyRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 4004000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4004000 | USD | 20251114 | Open filing evidence |
Real Estate Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 7062000 | USD | 20250331 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8329000 | USD | 20250331 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13865000 | USD | 20240401 | Open filing evidence |
Real Estate Segment · Management Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateSegmentMember;srt:ProductOrServiceAxis=us-gaap:ManagementServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250331 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1050000 | USD | 20250331 | Open filing evidence |
Real Estate Segment · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 57000 | USD | 20250331 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 210000 | USD | 20250331 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 26000 | USD | 20240401 | Open filing evidence |
Real Estate Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 1303000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4134000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1283000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2831000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1548000 | USD | 20250515 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1640000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 5257000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1800000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3617000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1818000 | USD | 20250515 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2002000 | USD | 20241119 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6065000 | USD | 20241119 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2072000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4062000 | USD | 20240813 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1990000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13865000 | USD | 20230414 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 3261000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 11120000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3523000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 7859000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4337000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 17205000 | USD | 20230414 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 4393000 | USD | 20221122 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 12807000 | USD | 20221122 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 4023000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 8414000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4391000 | USD | 20220531 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 17579000 | USD | 20220222 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 4767000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 13854000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4539000 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 9087000 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 4548000 | USD | 20210601 | Open filing evidence |
Real Estate Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 3261000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 11120000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3523000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 7859000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4337000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 17205000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 4393000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 12807000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 4023000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 8414000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4391000 | USD | 20230214 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 17579000 | USD | 20230214 | Open filing evidence |
Real Estate Services Segment · Rental Revenues
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:RealEstateServicesSegmentMember;srt:ProductOrServiceAxis=RHE:RentalRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 3000000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 10326000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3261000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 7326000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4065000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 4136000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 11980000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 3763000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 7844000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4081000 | USD | 20230214 | Open filing evidence |
Real Estate Services Segment · Management Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:ManagementServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 263000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 788000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 247000 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 525000 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 278000 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1045000 | USD | 20230414 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 255000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 774000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 255000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 519000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 265000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1021000 | USD | 20230414 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 248000 | USD | 20221122 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 743000 | USD | 20221122 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 247000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 495000 | USD | 20220823 | Open filing evidence |
Real Estate Services Segment · Management Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:RealEstateServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:ManagementServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 255000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 774000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 255000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 519000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 265000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 248000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 743000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 247000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 495000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 248000 | USD | 20230214 | Open filing evidence |
Real Estate Services Segment · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhe:RealEstateServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 107000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 103000 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 107000 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4000 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 26000 | USD | 20230414 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 6000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 20000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14000 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 91000 | USD | 20230414 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 9000 | USD | 20221122 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 84000 | USD | 20221122 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 13000 | USD | 20220823 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 75000 | USD | 20220823 | Open filing evidence |
Real Estate Services Segment · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=RHE:RealEstateServicesSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 6000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 20000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14000 | USD | 20230214 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 9000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 84000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 13000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 75000 | USD | 20230214 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 62000 | USD | 20230214 | Open filing evidence |
Healthcare Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhep:HealthcareServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 14001000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 26716000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 12715000 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 36050000 | USD | 20260402 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 8774000 | USD | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14416000 | USD | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 5642000 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 11273000 | USD | 20260402 | Open filing evidence |
Pharmacy Service
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhep:PharmacyServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 9655000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 17256000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 7601000 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 11722000 | USD | 20260402 | Open filing evidence |
Real Estate Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhep:RealEstateSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 5388000 | USD | 20260402 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 7062000 | USD | 20260402 | Open filing evidence |
Real Estate Segment · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhep:RealEstateSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 57000 | USD | 20260402 | Open filing evidence |
Real Estate Services Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rhep:RealEstateServicesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 786000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1632000 | USD | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 846000 | USD | 20260515 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1283000 | USD | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2831000 | USD | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1548000 | USD | 20260515 | Open filing evidence |
Corporate And Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2012-07-01 – 2012-09-30 | 3505000 | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-09-30 | 9487000 | USD | 20131022 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 3133000 Restated | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-06-30 | 5982000 Restated | USD | 20131022 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 2349000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-09-30 | 7646000 | USD | 20131022 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 2585000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-06-30 | 5297000 | USD | 20131022 | Open filing evidence |
Intersegment Elimination
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2012-07-01 – 2012-09-30 | -2918000 Restated | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-09-30 | -7849000 Restated | USD | 20131022 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | -2608000 Restated | USD | 20131022 | Open filing evidence |
| 2012-01-01 – 2012-06-30 | -4933000 Restated | USD | 20131022 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | -2109000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-09-30 | -6334000 | USD | 20131022 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | -2101000 | USD | 20131022 | Open filing evidence |
| 2011-01-01 – 2011-06-30 | -4315000 | USD | 20131022 | Open filing evidence |